New insider activity at Abbott Laboratories ( (ABT) ) has taken place on November 25, 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SVP Eric Shroff recently sold 1,586 shares of Abbott Laboratories stock, amounting to a total transaction value of $203,039.
Spark’s Take on ABT Stock
According to Spark, TipRanks’ AI Analyst, ABT is a Outperform.
Abbott Laboratories’ strong financial performance and positive earnings call are the most significant factors driving the stock score. The company’s robust growth in medical devices and international markets, along with effective cost management, supports a favorable outlook. Technical analysis and valuation provide a balanced view, with some caution due to market resistance and external challenges.
To see Spark’s full report on ABT stock, click here.
More about Abbott Laboratories
YTD Price Performance: 14.58%
Average Trading Volume: 6,164,761
Technical Sentiment Signal: Buy
Current Market Cap: $221.2B